iMSCs vs MSCs: Comparative Features and Therapeutic Potential in Wound Healing.

Area of Science:

• Regenerative Medicine
• Cell Therapy
• Wound Healing

Background:

• Mesenchymal stromal cells (MSCs) show therapeutic promise, but clinical translation of tissue-derived MSCs (tMSCs) is limited by variability and manufacturing challenges.
• Induced MSCs (iMSCs) derived from induced pluripotent stem cells (iPSCs) offer potential advantages over tMSCs.

Purpose of the Study:

• To comprehensively compare the characteristics, secretome, regenerative capacities, and therapeutic potential of tMSCs and iMSCs.
• To focus on their applications in wound healing and tissue regeneration.

Main Methods:

• Comparative analysis of cellular characteristics.
• Analysis of secretome composition, including growth factors, cytokines, and exosome cargo.
• Evaluation of regenerative capacities and therapeutic potential in various wound models.

Main Results:

• iMSCs demonstrate superior regenerative, immunomodulatory, and angiogenic benefits compared to tMSCs.
• iMSCs offer enhanced consistency and scalability for manufacturing.
• iMSCs promote angiogenesis, ECM production, re-epithelialization, and scarless wound healing in diverse wound types.

Conclusions:

• iMSCs represent a next-generation cell therapy for acute and chronic wound management.
• iMSCs hold promise for improved clinical outcomes and broader applicability in tissue regeneration.
• The advantages of iMSCs position them as a superior alternative to tMSCs for wound healing applications.